|3.||Atrial Flutter (Flutter, Atrial)
|1.||De Zuloaga, Claudio: 1 article (05/2015)|
|2.||Aguinaga, Luis: 1 article (05/2015)|
|3.||Fenelon, Guilherme: 1 article (05/2015)|
|4.||Labadet, Carlos: 1 article (05/2015)|
|5.||Scazzuso, Fernando: 1 article (05/2015)|
|6.||Patete, Manuel: 1 article (05/2015)|
|7.||Scanavacca, Mauricio: 1 article (05/2015)|
|8.||SOLAECE registry investigators: 1 article (05/2015)|
|9.||Uribe, William: 1 article (05/2015)|
|10.||Pozzer, Domingo: 1 article (05/2015)|
03/01/1998 - "Today, the majority of paroxysmal tachycardias can be cured by radiofrequency catheter ablation, obviating the need to use anti-arrhythmia drugs or open heart surgery. "
02/15/1978 - "[Effective electric cardioversion with low-energy stimuli in a patient with paroxysmal tachycardia treated previously with digitalis and anti-arrhythmia agents]."
03/01/2015 - "Tachycardia type was able to predict the response to antiarrhythmic drugs for children with EAT, sporadic tachycardia had best control rate on pharmacological therapy compared with paroxysmal tachycardia and incessant tachycardia (94% (15/16) vs. 67% (42/63) vs. 42% (15/36), χ2 = 17. "
11/01/1986 - "Diagnostic investigation of 36 patients with reciprocal paroxysmal tachycardias, using intracardiac electrophysiologic tests, revealed supraventricular paroxysmal tachycardia in 29 patients, and ventricular paroxysmal tachycardia in 7. Serial trials of antiarrhythmic drugs in acute experiments with simultaneous electrophysiologic studies made possible efficient medication in 80% of the patients. "
01/01/1976 - "The effects of two antiarrhythmic drugs (Verapamil, Amiodarone) on echo-zone duration, on initiation and on prophylactic long-term treatment of paroxysmal tachycardias are also reported and discussed."
|2.||Flecainide (Tambocor)FDA LinkGeneric
05/01/1987 - "[Electrophysiological effects and clinical efficacy of flecainide in childhood patients with supraventricular reciprocating paroxysmal tachycardia]."
05/01/1987 - "Intravenous flecainide acetate (2 mg/kg) was administered to 40 patients undergoing routine electrophysiological evaluation for the investigation of recurrent paroxysmal tachycardias. "
05/01/1987 - "Intravenous flecainide acetate for the clinical management of paroxysmal tachycardias."
02/01/1983 - "Flecainide acetate, a new class 1 agent, was therefore administered both intravenously and orally to 13 patients with recurrent paroxysmal tachycardia to assess whether the acute response to intravenous flecainide accurately predicts the response to oral therapy. "
06/01/1985 - "Flecainide is reported to be effective in patients with paroxysmal tachycardias, but its effect on rapid ventricular response over accessory atrioventricular pathway during atrial fibrillation is not known. "
|3.||Procainamide (Procan)FDA LinkGeneric
07/01/1985 - "Periodic procainamide for paroxysmal tachycardia."
06/01/1978 - "Effects of procainamide on atrioventricular nodal re-entrant paroxysmal tachycardia."
08/04/1961 - "[Contribution to the treatment of paroxysmal tachycardia with intravenous procaine amide]."
08/01/1960 - "[Procaine amide, by intravenous route, in 3 cases of paroxysmal tachycardia]."
07/01/1960 - "[Ventricular paroxysmal tachycardia treated by procamide with immediate beneficial effect]."
04/01/1994 - "Adenosine has proven efficacy in clinical trials and in the electrophysiological laboratory for the treatment of paroxysmal tachycardia. "
11/01/2003 - "Adenosine itself is used as a therapeutic agent for the treatment of supraventricular paroxysmal tachycardia and arrhythmias and as a vasodilatatory agent in cardiac imaging. "
06/21/1997 - "[Treatment with adenosine for supraventricular paroxysmal tachycardia during pregnancy]."
03/01/1997 - "Adenosine may be recommended as the drug of choice for treatment of paroxysmal tachycardia in young patients. "
03/01/1997 - "Adenosine is an effective, safe drug for the diagnosis and treatment of paroxysmal tachycardias in adult and pediatric patients. "
|5.||Digoxin (Digitek)FDA LinkGeneric
01/01/1997 - "A case report is described of supraventricular paroxysmal tachycardia with digoxin in utero therapy in which pharmacological intervention was successful. "
04/01/1980 - "Intrauterine digoxin treatment of fetal paroxysmal tachycardia. "
01/01/2008 - "Results of international multicentere studies demonstrate high efficacy of digoxin in treatment of chronic heart failure caused by compromised contractile activity of myocardium, atrium fibrillation and is used for controlling number of heart contractions and supraventricular paroxysmal tachycardia. "
|6.||Amiodarone (Amiodarona)FDA LinkGeneric
07/10/1994 - "Attacks of paroxysmal tachycardia were returned and aggravated by the hyperthyreosis induced by amiodarone. "
07/01/1989 - "[Effectiveness and electrophysiologic action of amiodarone in controlling attacks of supraventricular paroxysmal tachycardia]."
02/01/1986 - "We studied T4 and T3 kinetics and conversion of T4 to T3 in 5 men with recurrent paroxysmal tachycardia before and after 5-6 weeks of therapy with amiodarone (dose 200-800 mg/day). "
11/01/1985 - "In eight patients who had previously responded to treatment with oral amiodarone for prevention of recurrent supraventricular paroxysmal tachycardia, a new regimen of oral amiodarone dosing was evaluated. "
03/01/1985 - "[Treatment of resistant, recurrent paroxysmal tachycardias-- contribution of amiodarone]."
|7.||Disopyramide (Norpace)FDA LinkGeneric
05/01/1991 - "[Effect of ritmilen on myocardial refractility and cardiac impulse conduction in patients with paroxysmal tachycardia]."
03/01/1983 - "[Effect of intravenous disopyramide in supraventricular paroxysmal tachycardia refractory to vagal maneuvers]."
11/01/1979 - "The effect of intravenous disopyramide phosphate on recurrent paroxysmal tachycardias."
12/01/1978 - "There has been no recurrence of paroxysmal tachycardia in the four patients who have been maintained on oral therapy with disopyramide."
09/05/1970 - "[On the clinical trial of disopyramide (Rhythmodan) in the prevention of attacks of supraventricular paroxysmal tachycardia]."
05/01/1990 - "[Ethacizine intoxication in a patient with paroxysmal tachycardia]."
01/01/1988 - "[Clinical effectiveness of ethacizine in the treatment of supraventricular paroxysmal tachycardia]."
01/01/1991 - "The efficacy of ethacizine was investigated in 46 patients, whereas that of Bonnecor++ was examined in 31 patients who suffered from frequent episodes of supraventricular paroxysmal tachycardia. "
01/01/1991 - "[Comparative evaluation of the effects of ethacizine and Bonnecor in the treatment of supraventricular paroxysmal tachycardia]."
|9.||Moricizine (Moracizine)FDA Link
10/16/1987 - "Intravenous moricizine HCl terminated atrioventricular nodal reentrant paroxysmal tachycardia in 66% of patients, whereas 40% responded to the oral drug. "
11/01/1986 - "Ritmilen proved particularly effective in patients with paroxysmal tachycardias in the presence of the ventricular pre-excitation syndrome, while cordarone and etmozin were most effective antiarrhythmic drugs for reciprocal ventricular tachycardias. "
|10.||Antazoline (Antazoline Phosphate)FDA Link
01/01/1966 - "[Efficacy of antazoline in paroxysmal tachycardia]."
10/01/1981 - "Electrophysiologic studies were performed in 14 patients with atrioventricular nodal reentrant paroxysmal tachycardia (PSVT) before and after oral administration of 1.2-1.6 g quinidine sulfate over a 24-hour period (0.3-0.4 g every 6 hours). "
11/01/1985 - "Once per week oral administration of amiodarone in the prophylaxis of supraventricular paroxysmal tachycardia."
|5.||Electric Countershock (Cardioversion)
06/01/1982 - "Paroxysmal tachycardia and cardioversion during pregnancy."
12/01/1971 - "[Treatment of supraventricular paroxysmal tachycardia with repeated cardioversion in a 5-week-old child]."
05/15/1967 - "[Cardioversion in the treatment of paroxysmal tachycardias]."
01/01/1967 - "[Electric cardioversion in supraventricular paroxysmal tachycardia]."
01/01/1977 - "In the author's opinion, paired stimulation has its advantages over electric defibrillation in patients in a poor condition with paroxysmal tachycardia and the tachysystolic form of atrial fibrillation."